5th World Congress on Cancer Therapy
Department of General, Visceral and Oncosurgery, Pleißental-Klink Werdau, Germany
Title: Cytoreductive surgery and HIPEC for peritoneal carcinomatosis of a gallbladder carcinoma
Biography: Elke Wagler
Introduction: Th e prognosis of gallbladder carcinoma is extremely poor as tumors usually do not show any symptoms until they have become advanced. As a result, in most cases the tumor cannot be removed by surgery completely. Th e fi ve-year survival rate of patients is approximately 6-7%. Aft er diagnosis the median survival time is approximately four to fi ve months. If the carcinoma is removed completely, the fi ve-year survival rate will increase to 10-60%. Methods: One female patient with gallbladder carcinoma who had a primary R1 resection of the gallbladder, partial liver tissue as well as the Whipple procedure, developed a small bowel ileus aft er three months. Th is occured due to a large nodular peritoneal carcinomatosis without evidence of extra peritoneal metastasis. A primary cytoreductive surgery was performed followed by HIPEC. Results: Th e intra- and postoperative progress was uncomplicated with primary wound healing. Th e patient received an additive systematic chemotherapy aft er the completion of her rehabilitation. Th e current staging shows no evidence of recarcinomatosis or metastasis. Conclusion: Th e HIPEC is a modern technique which can be used especially for patients with metastatic cancer. In the current literature there can be hardly found any information on the practice of HIPEC in patients with metastatic gallbladder or bile duct carcinoma. An accurate selection of a potential patient plays a key role.